Gupta S, Allen-Vercoe E, Petrof EO
Curr Biol 12(9):735739 Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M, Dumitru CD, Shimizu M, Zupo S, Dono M, Alder H, Bullrich F, Negrini M, Croce CM (2004) An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues
With an average absorption rate of better than 90% vs
High-dose oral therapy (1000 micrograms daily) can be effective even in some malabsorption states due to passive diffusion mechanisms, though this is not standard first-line practice in the UK and should follow local policy
doi: 10.1345/aph.1Q722
Dihexa works through HGF/c-Met allosteric potentiation with structural synaptogenesis as the primary outcomeit has no human clinical trial data and effects in animals required multi-week treatment for full expression